FDA OKs Linaclotide in Young Children - Top-Institutions - MDSpire

FDA OKs Linaclotide in Young Children

Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.

  • By

  • Kathryn Wighton

  • May 27, 2026

  • 2 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and Surgeons

    New York, NY

    Key Differentiators

    • Pediatrics
    • Gastroenterology

  • #2

    National University Hospital
    National University Hospital

    Singapore, SG

    Key Differentiators

    • Pediatrics
    • Hematology-Oncology

  • #3

    BCHILD trial
    BCHILD trial

    N/A, N/A

    Key Differentiators

    • Pediatrics

Original Source(s)

FDA OKs Linaclotide in Young Children

  • by Kathryn Wighton

  • May 27, 2026

Related Content

Communicating with families during armed conflict: when healthcare systems fracture but phones remain

Powering Up: a qualitative evaluation of the art and science of meaningful co-production for health equity

Postoperative remodeling and developmental improvement of femoral trochlear dysplasia in pediatric habitual patellar dislocation